Factors influencing mortality in acromegaly.

By I. Holdaway, R. C. Rajasoorya, G. Gamble. Journal of Clinical Endocrinology and Metabolism, 2004

629 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/9dfc0d8e79e30f7a66e561d9cf4ccf540c1f8724

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. M. Molitch
2. S. Melmed

Citations in the corpus

• Guidelines for acromegaly management: an update. (2009, methodology): “Based on the fact that basalGHlevelsabove2.5ng/ml(15,78),elevatedIGF-I(12,14, 78), age and disease duration (14, 78 ), hypertension (78), diabetes,andcardiacdiseasearethemaindeterminantsofmortality HQ, biochemical goals to control mortality are a GH less than 2.5 ng/ml or a normal age and sex-adjus”
• A consensus on criteria for cure of acromegaly. (2010, background): “In patients with discordant GH and IGF-I levels, the mortality risk does not appear to be elevated, but data are still insufficient (VLQ) (51).”